N-tert-Butoxycarbonyl-D-glutamic acid 5-benzyl ester | CAS:35793-73-8

We serve N-tert-Butoxycarbonyl-D-glutamic acid 5-benzyl ester CAS:35793-73-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-tert-Butoxycarbonyl-D-glutamic acid 5-benzyl ester

Chemical Name: (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-5-phenylmethoxypentanoic acid
CAS.NO: 35793-73-8
Molecular Formula: C17H23NO6
Molecular Weight: 337.36800

Synonyms:
N-tert-Butoxycarbonyl-D-glutamic acid 5-benzyl ester
AmbotzBAA1354
Boc-D-Glutamicacid5-benzylester

Physical and Chemical Properties:
Density: 1.197g / cm3
Boiling point: 522.6ºC at 760 mmHg
Melting point: 69-71ºC
Flash point: 269.9ºC
Refractive index: 1.523

Specification:
Appearance: White Powder
Purity:≥98%
Related Substance (TLC):One spot

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage: 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.



Contact us for information like (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-5-phenylmethoxypentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boc-D-Glutamicacid5-benzylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-tert-Butoxycarbonyl-D-glutamic acid 5-benzyl ester Use and application,(2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxo-5-phenylmethoxypentanoic acid technical grade,usp/ep/jp grade.


Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.Dimethyl phosphonate manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).1,2,3-Trichloropropene supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).5-Methoxy-7-azaindole vendor The World Health Organisation (WHO) describes coronaviruses as a large family of viruses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China.The World Health Organisation (WHO) describes coronaviruses as a large family of viruses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China.